| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |